Post by Exploration of Targeted Anti-tumor Therapy

ETAT 2025 #AnnualDevelopmentReport – A Year of Growth and Impact   The year 2025 marked a period of significant progress for ETAT in the field of #AcademicPublishing, with multiple key metrics demonstrating steady growth. While continuing to publish high-quality articles, the journal leveraged a diverse editorial board with international perspectives and implemented a series of strategic promotions and collaborative efforts, effectively enhancing its academic influence and external recognition. This progress was clearly reflected in the consistently improving citation performance over the past year. These achievements fully underscore ETAT's ongoing development and expanding academic impact within the field of #OncologyResearch. We sincerely thank our Editor-in-Chief, #EditorialBoardMembers, #GuestEditors, #Reviewers, and #Authors for their exceptional contributions throughout 2025. In the coming year, ETAT looks forward to continued partnership with the academic community to foster open communication and drive innovation in oncology research. Researchers are warmly invited to submit their work, follow our latest developments, and explore opportunities for collaboration. -------------------------- 👍 Contribute Your Research 📚 Exploration of Targeted Anti-tumor Therapy invites high-quality submissions: 📩 Contact us: [email protected] 📊 #PubMed/PMC, #Scopus (#CiteScoreTracker 5.3), and #GoogleScholar indexed | #MeanCitation: 8.57 #OpenAccess #CancerResearch #Tumor #Oncology #AcademicPublishing #CancerTreatment #PrecisionMedicine